CONNECT WITH US:
Aug 15, 2017 20:00 JST
Singapore eDevelopment Ltd
Singapore eDevelopment's Global BioLife and Chemia Corp. to develop 3F suite of Functional Fragrances
SINGAPORE, Aug 15, 2017 - (ACN Newswire) - Singapore eDevelopment Ltd (SeD; SGX:SGE) has announced that its indirect subsidiary, Global BioLife Inc., is collaborating with U.S.-based Chemia Corporation to develop specialised fragrances which can counter mosquito-borne diseases, diminish stress and anxiety, and act in anti-viral medical applications.
3F (Functional Fragrance Formulation) is a suite of functional fragrances being developed. The first product, 3F Mosquito, is made of specialised oils sourced from botanicals which mosquitoes avoid. 3F Mosquito was designed with an objective to identify, then create a suitable formula that was pleasant, yet excels in providing layers of protection against mosquitoes.
Daryl Thompson, Global BioLife Director of Scientific Initiatives, leads the 3F research. "The specialised oils in 3F Mosquito are scientifically proven to affect a mosquito's receptors, essentially making the mosquito blind to your presence," says Thompson.
In addition to 3F Mosquito, Global BioLife and Chemia are developing fragrances as additives for use in laundry detergents, shampoos and lotions, providing additional layers of protection against mosquitoes, and developing advanced coatings for industrial and medical applications.
"Biomedical science has become increasingly vital. Global BioLife is taking steps toward providing solutions to issues that have plagued the biomedical field for decades. This working collaboration marks a first steps in actively changing the game of healthcare," said Chan Heng Fai, SeD Executive Chairman and Chief Executive Officer, and a Global BioLife Director.
Global BioLife is an 80%-held subsidiary of SeD wholly-owned Global BioMedical Inc. The remaining shareholding in Global BioLife is held by Thompson's GRDG Sciences LLC and Australia Securities Exchange-listed Holista CollTech Limited, in equal proportions of 10% each.
About Chemia Corporation
Chemia Corporation provides high quality, cost effective fragrances to the manufacturers of personal care, household and industrial & institutional products. Thomas A. Meyer is the Vice-President of Innovation and Sustainability. For further information, please visit www.chemiacorp.com.
About GRDG Sciences LLC
GRDG Sciences LLC is a natural products discovery drug research company incorporated in Florida, USA. The Company was set up by natural products scientist Daryl Thompson. Thompson is a biochemist, nominated for the Nobel Prize in 2015 and 2016 for his research in pandemic technology.
About Holista CollTech Ltd
Holista CollTech is incorporated in Australia and listed on the Australian Securities Exchange. A research-driven biotechnology company, Holista focuses on research and development of product in the natural products space. Founder and Chief Executive Officer Dr Rajen Manicka holds a PhD in Holistic Medicine and a Masters of Business Administration. For further information, please visit www.holistaco.com.
About Singapore eDevelopment Ltd
Singapore eDevelopment Ltd (SeD) was incorporated on 9 Sept 2009, and listed by SGX Catalist (SGX:SGE) in July 2010. SeD is involved in (i) property development and investments primarily in the United States and Western Australia; (ii) information technology related businesses; (iii) development, research, testing, manufacturing, licensing and distribution of biomedical products; and (iv) investment activities. For more information, please visit: www.SeD.com.sg.
Issued for the Company:
WeR1 Consultants Pte Ltd
Tel : +65 6737 4844
Source: Singapore eDevelopment Ltd
Sectors: HealthCare, Alternatives, Cosmetics/Spec.Chem
Copyright ©2020 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
AbbVie and Eisai Announce an Approval for Partial Changes in the Marketing Approval of HUMIRA, a Fully Human Anti-TNFalpha Monoclonal Antibody
May 29, 2020 15:54 JST
Sharp Releases Notice of Corporate Spin-Off of the Display Device Business Division
May 29, 2020 15:47 JST
DENSO Announces Changes in the Areas of Responsibility of Senior Executive Officers and Executive Officers
May 29, 2020 12:05 JST
Eisai: Results from LENVIMA (lenvatinib) plus KEYTRUDA (pembrolizumab) Trials
May 29, 2020 11:31 JST
Hitachi Announces Change in the Effective Date for Company Split and Closing Date of Share Transfer
May 28, 2020 19:18 JST
Mitsubishi Motors Announces Production, Sales and Export Figures for April 2020
May 28, 2020 19:09 JST
Honda Sets Monthly Records for Automobile Production in China
May 28, 2020 18:52 JST
Mazda Production and Sales Results for April 2020
May 28, 2020 16:46 JST
Mazda Joins IP Open Access Declaration Against Covid-19
May 28, 2020 16:28 JST
Toyota Releases Sales, Production, and Export Results for April 2020
May 28, 2020 13:56 JST
Fujitsu Accelerates Digital Transformation with Flexible, Scale-out Software-Defined Storage ETERNUS Data Services Platform
May 28, 2020 11:26 JST
Alliance New Cooperation Business Model to Support Member-Company Competitiveness and Profitability
May 27, 2020 18:28 JST
eK X and eK Wagon Achieve Top Ratings for Preventive and Collision Safety Performance in JNCAP
May 27, 2020 15:31 JST
2019 JNCAP Assessment on Toyota Vehicles Announced
May 27, 2020 14:07 JST
Fujitsu Launches 14 New Models of Enterprise Notebooks, Tablets and Workstations Optimized for Remote Work
May 26, 2020 11:10 JST
Fujitsu Develops AI-Video Recognition Technology to Promote Hand Washing Etiquette and Hygiene in the Workplace
May 26, 2020 10:34 JST
Mitsubishi Motors Joins OPEN COVID-19 DECLARATION
May 26, 2020 09:34 JST
Tokyo Metropolitan Government to trial 5G Antenna-equipped Smart Poles in Cooperation with Sumitomo Corporation and NEC
May 25, 2020 10:44 JST
Mazda Begins Providing, Virtual Racing Car, Mazda RX-Vision GT3 Concept Online
May 22, 2020 14:26 JST
'e5 Consortium' Established to Promote Zero-Emission Electric Vessel
May 21, 2020 15:34 JST
More Latest Release >>
Impact Biomedical's Majority Owned Next Generation Medical Technologies Valued at USD 592 Million (SGD 841 Million) by Independent Experts
April 24 2020 10:00 JST
Impact BioMedical's Linebacker and Equivir inhibit SARS-CoV-2, virus responsible for the COVID-19 outbreak
March 18 2020 11:00 JST
Global BioLife to Present 3F Antimicrobial Fragrance at 2020 ASM Biothreats
November 15 2019 02:00 JST
Global BioLife to present Functional Fragrance Formula at the American Society for Microbiology's Biothreats Conference as a New Method to Prevent and Treat Tuberculosis
October 29 2019 09:00 JST
Global BioLife unveils naturally modified Laetose at Harvard Global Catalyst Health Summit
July 24 2019 15:00 JST
Global BioLife's 3F Mosquito Repellent Formula performs well in Independent Testing
June 12 2019 14:00 JST
Global BioLife's 3F Antimicrobial Fragrance shows Efficacy against Tuberculosis
January 28 2019 12:00 JST
Singapore eDevelopment's Global BioLife to present Parkinson's Research at Neuroscience 2018
November 07 2018 19:00 JST
Singapore eDevelopment Limited Announces Corporate and Business Update
June 18 2018 19:00 JST
Singapore eDevelopment's Global BioLife develops Low Glycemic Modified Sugar
May 31 2018 18:00 JST
More Press release >>